SCHEMBL7465420

SCHEMBL7465420

CCc1cc2nc(OC)c(OC)nc2c(NS(C)(=O)=O)c1Cl

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.33
HIF1A Q16665 2/20 0.33
CCR4 P51679 4/20 0.33
NPY1R P25929 2/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
PDE10A Q9Y233 3/20 0.32
BRAF P15056 1/20 0.32
EPHX2 P34913 1/20 0.32
GRM1 Q13255 1/20 0.32
KDM4E B2RXH2 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
PIK3CA P42336 2/20 0.31
PDCD1LG2 Q9BQ51 1/20 0.31
CD274 Q9NZQ7 1/20 0.31
PIK3CD O00329 3/20 0.31
PIK3CB P42338 1/20 0.31
PIK3CG P48736 1/20 0.31
SLC22A1 O15245 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8935311 0.96 SMN1; SMN2 (0.32) SMN1; SMN2HIF1ACCR4NPY1RALDH1A1
SCHEMBL7467654 0.85 NPY1R (0.37) SMN1; SMN2HIF1ACCR4NPY1RALDH1A1
SCHEMBL7466587 0.85 CCR4 (0.36) SMN1; SMN2HIF1ACCR4NPY1RALDH1A1
SCHEMBL7468793 0.84 CCR4 (0.36) SMN1; SMN2HIF1ACCR4NPY1RALDH1A1
SCHEMBL7470948 0.84 GLP1R (0.33) SMN1; SMN2HIF1ACCR4NPY1RALDH1A1
SCHEMBL7475650 0.81 CCR4 (0.35) CCR4KDM4EMAPTPIK3CAPIK3CD
SCHEMBL7476942 0.79 ALDH1A1 (0.38) SMN1; SMN2HIF1ACCR4NPY1RALDH1A1
SCHEMBL7462801 0.78 CCR4 (0.36) SMN1; SMN2HIF1ACCR4BRAFLMNA
SCHEMBL8935248 0.78 PIK3CA (0.32) PIK3CA
SCHEMBL7468982 0.76 ALDH1A1 (0.45) SMN1; SMN2HIF1ANPY1RALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0783495-B1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER LTD (GB) 2002-02-27 EP disclosed
US-5863917-A ANXIOLYTIC AGENT, ANTICONVULSANTS, ANALGESICS AND NEUROPROTECTIVES. PFIZER, INC. (US) 1999-01-26 US disclosed
US-5852016-A Quinoxaline derivatives useful in therapy PFIZER INC. (US) 1998-12-22 US disclosed
WO-1997031902-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-04 WO disclosed
EP-0792874-A1 Quinoxaline derivatives useful in therapy Pfizer Limited (GB) 1997-09-03 EP disclosed
EP-0783495-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY Pfizer Limited (GB) 1997-07-16 EP disclosed
WO-1996009295-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER LIMITED (GB) 1996-03-28 WO disclosed